India-headquartered pharma major Lupin has signed a license and supply agreement with OLIC (Thailand), a subsidiary of Japanese pharmaceutical company Fuji Pharma Co., for marketing Nextstellis (drospirenone and estetrol tablets) in Vietnam and Philippines.
Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement Relates to the submission of a marketing approval application in JapanMarks strong...
Vistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License to Develop and Commercialize Vistagen’s Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement Relates to completion of the interim clinical study reports of Phase 3 trials in patients...